---
schema_version: "secwatch.filing_event.v1"
accession: "0001013762-23-004638"
form_type: "8-K"
ticker: "PHGE"
cik: "0001739174"
company_name: "BiomX Inc."
filed_at: "2023-10-18T23:59:59+00:00"
generated_at: "2026-06-09T21:53:33.703906+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# BiomX appoints Eddie Williams as Class I Director to fill board vacancy

## Summary
- Eddie Williams appointed Class I Director, term expires at 2024 annual meeting.
- Williams is independent under NYSE American rules and entered indemnification agreement.
- He currently serves on BioAtla (BCAB) board; previously Catalyst Biosciences (CBIO) board.
- Previously SVP at Novo Nordisk and VP at Novartis; over 20 years pharma experience.
- Appointment effective October 12, 2023; no arrangement with any other person.

## SEC filing metadata
- accession: 0001013762-23-004638
- form_type: 8-K
- ticker: PHGE
- cik: 0001739174
- company_name: BiomX Inc.
- filed_at: 2023-10-18T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1739174/000101376223004638/0001013762-23-004638-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1739174/000101376223004638/ea186892-8k_biomx.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001013762-23-004638
- JSON: https://secwatch.observer/filing/0001013762-23-004638.json
- Plain text: https://secwatch.observer/filing/0001013762-23-004638.txt

## Key facts
- Executive change
  Eddie Williams was appointed as Class I Director at BiomX Inc..
  - Action: appointed
  - Role: Class I Director
  source text: On October 12, 2023, the Board of Directors (the “Board”) of BiomX Inc. (the “Company”), pursuant to a recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Eddie Williams to serve as Class I Director of the Company, with a term expiring at the Company’s 2024 annual meeting of stockholders, in order to fill an existing vacancy on the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1739174/000101376223004638/0001013762-23-004638-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.